Improved Case Detection and Vector Control for Visceral Leishmaniasis
NCT03269006 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 202
Last updated 2020-01-14
Summary
Visceral leishmaniasis (VL) also known as kala-azar is a public health problem in Bangladesh. Since 2005 a national kala-azar elimination program is going on in the country. The program has preparatory, attack, consolidation and maintenance phases. The target of the program is to reduce the VL incidence less than 1 per 10,000 people at upazila (sub-district) level in VL endemic upazilas of the country. The program is heading successfully to its consolidation phase.
During attack phase house to house search for VL suspects and also suspects with Post-kala-azar Dermal Leishmaniasis (PKDL) was the tool for early diagnosis of VL and PKDL cases. Indoor residual spraying with insecticide (Deltamethrin) was the method for sand fly control to reduce the transmission of the disease. Since in the consolidation phase the VL case load is many times less than that in the attack phase, house to house search for VL and PKDL cases and IRS for vector control is no more cost-effective for the program. Therefore there is a need for alternative methods for active search of VL and PKDL cases and method for sand fly control, appropriate for the consolidation phase.
In the present study the investigators propose to investigate the efficacy of Inesfly 5AIGRNG TM containing Alphacypermethrin 0.7%; D-Allethin 1.0% and Pyriproxyphen (0.063%), commercial available durable wall lining (DWL), impregnated of existing bed-net with insecticide tablet, KO TAB 123, indoor residual spraying (IRS) with Delthamethrin against a control group Methods: A cluster randomized controlled design to measure sand fly density reduction at intervention household as well as sand fly mortality by entomological methods.
Outcome measures/variables: reduction of sand fly density at intervention household and sand fly corrected mortality on intervention surfaces compare to control households/conditions.
Conditions
- Visceral Leishmaniasis
Interventions
- DEVICE
-
Inesfly Paint
Inesfly 5AIGRNG TM paint contain Alphacypermethrin 0.7%; D-Allethin 1.0% and Pyriproxyphen (0.063%). Others intervention such as IRS, ITN and IDWLcontain Delthamethrin
- DEVICE
-
IDWL (1m)
Install durable wall lining up to one meter from the floor of the intervention room containing deltamethrin to kill immature stage and as well as adult sand flies
- DEVICE
-
ITN (KO-Tab 123)
Impregnation of existing bed net by the insecticide tablet, K-O Tab 1-2-3 containing deltamethrin
- DEVICE
-
IRS (Delthamethrin)
Indoor residual spraying with Delthamethrin in the living rooms
Sponsors & Collaborators
-
International Centre for Diarrhoeal Disease Research, Bangladesh
lead OTHER
Principal Investigators
-
Dinesh Mondal, PhD · Senior Scientist
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-01
- Primary Completion
- 2016-04-30
- Completion
- 2019-07-30
Countries
- Bangladesh
Study Locations
More Related Trials
-
Evaluation of Less Invasive Procedures for Visceral Leishmaniasis Treatment Efficacy Monitoring Test of Cure
NCT05426577 ·Status: UNKNOWN
-
Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants
NCT00001906 ·Status: COMPLETED ·Phase: PHASE1
-
Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation Study
NCT06118749 ·Status: TERMINATED
-
Efficacy, Acceptability and Cost-effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala Azar
NCT00318721 ·Status: COMPLETED ·Phase: NA
-
Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India
NCT00486382 ·Status: COMPLETED ·Phase: PHASE1
-
Miltefosine for Brazilian Visceral Leishmaniasis
NCT00378495 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Fractional CO2 Laser With Topical Pentostam Treatment for Cutaneous Leishmaniasis.
NCT03009422 ·Status: UNKNOWN ·Phase: NA
-
ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE -
NCT03303898 ·Status: COMPLETED ·Phase: NA
-
A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL)
NCT01975051 ·Status: COMPLETED ·Phase: PHASE4
-
Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World
NCT00703924 ·Status: COMPLETED ·Phase: PHASE2
-
Enhancing Protection Against Vector-borne Diseases in Forcibly Displaced Communities: Evaluating the Efficacy of Spatial Repellents for Cutaneous Leishmaniasis Control in North-East Syria
NCT06917040 ·Status: COMPLETED ·Phase: PHASE3
-
Miltefosine for Children With PKDL
NCT02193022 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis
NCT01011309 ·Status: COMPLETED ·Phase: PHASE2
-
Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With Positive Response to Leishmanin (LST>0)
NCT00429780 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers
NCT02071758 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Safety and Efficacy of a Leishmania Vaccine to Prevent Post Kala Azar Dermal Leishmaniasis (PKDL)
NCT04107961 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety and Efficacy of CIS43LS Anti-malaria mAb in Mali
NCT04329104 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in Bangladesh
NCT03311607 ·Status: COMPLETED ·Phase: PHASE4
-
The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil
NCT02530697 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With no Response to Leishmanin
NCT00429715 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Investigation of Infections Due to Leishmanial Parasites
NCT00001169 ·Status: COMPLETED
-
Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis
NCT00111514 ·Status: COMPLETED ·Phase: PHASE1
-
Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis
NCT00604955 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis
NCT00111553 ·Status: COMPLETED ·Phase: PHASE1
-
Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus Infection
NCT00790998 ·Status: COMPLETED ·Phase: PHASE3